542 related articles for article (PubMed ID: 28405721)
1. Genome editing: a robust technology for human stem cells.
Chandrasekaran AP; Song M; Ramakrishna S
Cell Mol Life Sci; 2017 Sep; 74(18):3335-3346. PubMed ID: 28405721
[TBL] [Abstract][Full Text] [Related]
2. Genome Editing in Stem Cells for Disease Therapeutics.
Song M; Ramakrishna S
Mol Biotechnol; 2018 Apr; 60(4):329-338. PubMed ID: 29516417
[TBL] [Abstract][Full Text] [Related]
3. [CRISPR/Cas9 technology in disease research and therapy: a review].
Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in stem cells and gene editing: Drug discovery and therapeutics.
Bayarsaikhan D; Bayarsaikhan G; Lee B
Prog Mol Biol Transl Sci; 2021; 181():231-269. PubMed ID: 34127195
[TBL] [Abstract][Full Text] [Related]
5. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
Mashimo T
Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
[TBL] [Abstract][Full Text] [Related]
6. INDEL detection, the 'Achilles heel' of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels.
Bennett EP; Petersen BL; Johansen IE; Niu Y; Yang Z; Chamberlain CA; Met Ö; Wandall HH; Frödin M
Nucleic Acids Res; 2020 Dec; 48(21):11958-11981. PubMed ID: 33170255
[TBL] [Abstract][Full Text] [Related]
7. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
Eid A; Mahfouz MM
Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
[TBL] [Abstract][Full Text] [Related]
8. Genome editing in cardiovascular diseases.
Mani I
Prog Mol Biol Transl Sci; 2021; 181():289-308. PubMed ID: 34127197
[TBL] [Abstract][Full Text] [Related]
9. hPSC gene editing for cardiac disease therapy.
Saleem A; Abbas MK; Wang Y; Lan F
Pflugers Arch; 2022 Nov; 474(11):1123-1132. PubMed ID: 36163402
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
[TBL] [Abstract][Full Text] [Related]
11. Genome Editing in Human Pluripotent Stem Cells.
Carlson-Stevermer J; Saha K
Methods Mol Biol; 2017; 1590():165-174. PubMed ID: 28353269
[TBL] [Abstract][Full Text] [Related]
12. Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications.
Chang CY; Ting HC; Su HL; Jeng JR
Cell Transplant; 2018 Mar; 27(3):379-392. PubMed ID: 29806481
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas Derivatives as Novel Gene Modulating Tools: Possibilities and In Vivo Applications.
Xu X; Hulshoff MS; Tan X; Zeisberg M; Zeisberg EM
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344896
[TBL] [Abstract][Full Text] [Related]
14. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
Guha TK; Edgell DR
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Delivery Systems for Therapeutic Genome Editing.
Wang L; Li F; Dang L; Liang C; Wang C; He B; Liu J; Li D; Wu X; Xu X; Lu A; Zhang G
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128905
[TBL] [Abstract][Full Text] [Related]
16. Concerns regarding 'off-target' activity of genome editing endonucleases.
Kadam US; Shelake RM; Chavhan RL; Suprasanna P
Plant Physiol Biochem; 2018 Oct; 131():22-30. PubMed ID: 29653762
[TBL] [Abstract][Full Text] [Related]
17. Using Gene Editing Approaches to Fine-Tune the Immune System.
Pavlovic K; Tristán-Manzano M; Maldonado-Pérez N; Cortijo-Gutierrez M; Sánchez-Hernández S; Justicia-Lirio P; Carmona MD; Herrera C; Martin F; Benabdellah K
Front Immunol; 2020; 11():570672. PubMed ID: 33117361
[TBL] [Abstract][Full Text] [Related]
18. Highly efficient biallelic genome editing of human ES/iPS cells using a CRISPR/Cas9 or TALEN system.
Takayama K; Igai K; Hagihara Y; Hashimoto R; Hanawa M; Sakuma T; Tachibana M; Sakurai F; Yamamoto T; Mizuguchi H
Nucleic Acids Res; 2017 May; 45(9):5198-5207. PubMed ID: 28334759
[TBL] [Abstract][Full Text] [Related]
19. To CRISPR and beyond: the evolution of genome editing in stem cells.
Chen KY; Knoepfler PS
Regen Med; 2016 Dec; 11(8):801-816. PubMed ID: 27905217
[TBL] [Abstract][Full Text] [Related]
20. Construction and Evaluation of Zinc Finger Nucleases.
Ochiai H; Yamamoto T
Methods Mol Biol; 2023; 2637():1-25. PubMed ID: 36773134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]